10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Drug-induced regulatory overcompensation has motivational consequences: Implications for homeostatic and allostatic models of drug addiction

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Initial administration of 60% nitrous oxide (N 2O) at 21°C ambient temperature reduces core temperature (Tc) in rats, but tolerance develops to this hypothermic effect over several administrations. After additional N 2O administrations, a hyperthermic overcompensation (sign-reversal) develops such that Tc exceeds control levels during N 2O inhalation. This study investigated whether rats would employ behavioral thermoregulation to facilitate, or oppose, a previously acquired hyperthermic overcompensation during N 2O administration. To establish a hyperthermic sign-reversal, male Long-Evans rats (N = 12) received 10 3-h administrations of 60% N 2O while housed in a gas-tight, live-in, “inactive” thermal gradient (∼21°C). Following the tenth N 2O exposure, the thermal gradient was activated (range of 10–37°C), and rats received both a control gas session and a 60% N 2O test session in counterbalanced order. Mean Tc during N 2O inhalation in the inactive gradient was reliably hypothermic during the first exposure but was reliably hyperthermic by the tenth exposure. When subsequently exposed to 60% N 2O in the active gradient, rats selected a cooler Ta, which blunted the hyperthermic sign-reversal and lowered Tc throughout the remainder of the N 2O exposure. Thus, autonomic heat production effectors mediating the hyperthermia were opposed by a behavioral effector that promoted increased heat loss via selection of a cooler ambient temperature. These data are compatible with an allostatic model of drug addiction that suggests that dysregulatory overcompensation in the drugged-state may motivate behaviors (e.g., drug taking) that oppose the overcompensation, thereby creating a vicious cycle of escalating drug consumption and recurring dysregulation.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: not found

          Do multiple outcome measures require p-value adjustment?

          Background Readers may question the interpretation of findings in clinical trials when multiple outcome measures are used without adjustment of the p-value. This question arises because of the increased risk of Type I errors (findings of false "significance") when multiple simultaneous hypotheses are tested at set p-values. The primary aim of this study was to estimate the need to make appropriate p-value adjustments in clinical trials to compensate for a possible increased risk in committing Type I errors when multiple outcome measures are used. Discussion The classicists believe that the chance of finding at least one test statistically significant due to chance and incorrectly declaring a difference increases as the number of comparisons increases. The rationalists have the following objections to that theory: 1) P-value adjustments are calculated based on how many tests are to be considered, and that number has been defined arbitrarily and variably; 2) P-value adjustments reduce the chance of making type I errors, but they increase the chance of making type II errors or needing to increase the sample size. Summary Readers should balance a study's statistical significance with the magnitude of effect, the quality of the study and with findings from other studies. Researchers facing multiple outcome measures might want to either select a primary outcome measure or use a global assessment measure, rather than adjusting the p-value.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Addiction motivation reformulated: an affective processing model of negative reinforcement.

            This article offers a reformulation of the negative reinforcement model of drug addiction and proposes that the escape and avoidance of negative affect is the prepotent motive for addictive drug use. The authors posit that negative affect is the motivational core of the withdrawal syndrome and argue that, through repeated cycles of drug use and withdrawal, addicted organisms learn to detect interoceptive cues of negative affect preconsciously. Thus, the motivational basis of much drug use is opaque and tends not to reflect cognitive control. When either stressors or abstinence causes negative affect to grow and enter consciousness, increasing negative affect biases information processing in ways that promote renewed drug administration. After explicating their model, the authors address previous critiques of negative reinforcement models in light of their reformulation and review predictions generated by their model.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Addiction and the brain antireward system.

              A neurobiological model of the brain emotional systems has been proposed to explain the persistent changes in motivation that are associated with vulnerability to relapse in addiction, and this model may generalize to other psychopathology associated with dysregulated motivational systems. In this framework, addiction is conceptualized as a cycle of decreased function of brain reward systems and recruitment of antireward systems that progressively worsen, resulting in the compulsive use of drugs. Counteradaptive processes, such as opponent process, that are part of the normal homeostatic limitation of reward function fail to return within the normal homeostatic range and are hypothesized to repeatedly drive the allostatic state. Excessive drug taking thus results in not only the short-term amelioration of the reward deficit but also suppression of the antireward system. However, in the long term, there is worsening of the underlying neurochemical dysregulations that ultimately form an allostatic state (decreased dopamine and opioid peptide function, increased corticotropin-releasing factor activity). This allostatic state is hypothesized to be reflected in a chronic deviation of reward set point that is fueled not only by dysregulation of reward circuits per se but also by recruitment of brain and hormonal stress responses. Vulnerability to addiction may involve genetic comorbidity and developmental factors at the molecular, cellular, or neurocircuitry levels that sensitize the brain antireward systems.
                Bookmark

                Author and article information

                Journal
                Temperature (Austin)
                Temperature (Austin)
                KTMP
                ktmp20
                Temperature: Multidisciplinary Biomedical Journal
                Taylor & Francis
                2332-8940
                2332-8959
                Oct-Dec 2014
                31 October 2014
                31 October 2014
                : 1
                : 3 , Temperature and Toxicology with Focus on Drugs of Abuse; Guest Editors: Félix Carvalho, PharmD, PhD; Eugene A Kiyatkin, MD, PhD; and Daniel E Rusyniak, MD
                : 248-256
                Affiliations
                [1 ]Departments of Oral Health Sciences; University of Washington ; Seattle, WA USA
                [2 ]Orthodontics; University of Washington ; Seattle, WA USA
                [3 ]Pediatric Dentistry; University of Washington ; Seattle, WA USA
                [4 ]Department of Psychiatry and Behavioral Neuroscience; University of Cincinnati ; Cincinnati, OH USA
                Author notes
                [* ]Correspondence to: Douglas S Ramsay; Email: ramsay@ 123456uw.edu
                Article
                944802
                10.4161/23328940.2014.944802
                4415621
                25938126
                37ec7f1f-6039-4c71-ad28-528c42493441
                © 2014 The Author(s). Published with license by Taylor & Francis Group, LLC

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.

                History
                : 31 March 2014
                : 19 June 2014
                : 26 June 2014
                Page count
                Figures: 4, Tables: 0, References: 23, Pages: 9
                Categories
                Research Paper

                allostasis,drug tolerance,homeostasis,nitrous oxide,thermoregulation

                Comments

                Comment on this article